Group of Nations SUMMITSSolutions Through Inclusivityby Group of Nations

Publisher of the first-ever G7 Summit publication, Denver 1997

See where your company fits

A question for your company

Which analysis on this page could your company add a solution to?

Share your answer over a virtual coffee & a chat →
An Official Publication of America250. Declaring Freedom: the founders and the birth of a nation. Order your copy at shop.groupofnations.com An Official Publication of America250. Icons of the Open Road: Route 66 and landmarks from all 50 states. Order your copy at shop.groupofnations.com An Official Publication of America250. Gridiron Evolution: America’s game, from Canton to the world. Order your copy at shop.groupofnations.com An Official Publication of America250. To the Moon and Beyond: America’s space legacy. Order your copy at shop.groupofnations.com
Official America250 Commemorative Posters in Full Color, Old Style and Black & White, 18 x 24 in. Order at shop.groupofnations.com
With congratulations on America’s 250th Anniversary, from JMI-IBNF, PEACE and the Global Alliance CouncilAdvertisement
Group of Nations supports Birmingham Care Group as its charity of choice. Donate now at birminghamcaregroup.org Sea Menace, a feature documentary on sargassum. One fisherman. One bloom. One ocean. One world connected. Supported by Groupofnations.com. Donate now at gofundme.com/f/support-sea-menace

Analysis · B20 · Health innovation

B20 asks the G20 to cut time to market for new medical technologies by 30%

The B20 USA Leaders' Statement sets out health care recommendations on harmonized safety approvals, electronic health records, reimbursement and the use of AI in research.

October 21, 2026 · 3 min read

Exterior of Building 64 at the U.S. Food and Drug Administration campus in White Oak, Maryland
FDA Building 64, White Oak, Maryland. Photo: U.S. Food and Drug Administration, via Wikimedia Commons (public domain)

Health care has a distinct place in the B20 USA Leaders’ Statement, the policy document the U.S. Chamber of Commerce has published ahead of the B20 USA Summit in Washington, November 9 to 11, 2026. Under its Innovation Task Force, the statement asks G20 governments to reduce the time between marketing authorization and patient access for new medical solutions and technologies by 30% by 2030.

For pharmaceutical, medical device and health technology companies, the recommendations address the steps that sit between regulatory approval and revenue: duplicative national reviews, fragmented health data systems and slow coverage decisions.

Four recommendations

The health priority, labeled I3 in the statement, has four parts. The first asks governments to explore harmonization of safety approvals so that proven solutions can be deployed faster. The second calls for a unified set of standards and guidelines for electronic health record systems within each country. The third asks governments to use reimbursement pathways to reduce unnecessary coverage delays for innovative products. The fourth calls for a transparent global understanding of how AI is used, both to improve access to care and to support AI-based research.

The statement supports the AI item with a data point: it reports that a subset of AI-designed drug candidates has shown Phase I success rates of 80% to 90%, compared with a historical range of 40% to 65%. The statement presents this as evidence that regulators need the capacity to assess AI-generated research.

Where it sits in the B20 process

The Innovation Task Force is chaired by David Zapolsky, Chief Global Affairs and Legal Officer of Amazon. Its other priorities cover long-term research and development incentives, trust in digital innovation and industrial technology. The Leaders’ Statement was prepared with the Boston Consulting Group as knowledge partner, and the Chamber describes it as a foundation for conversations and action at the Washington summit and beyond. The G20 Leaders’ Summit follows at Trump National Doral in Miami on December 14 and 15.

Health is not one of the four working groups of the U.S. G20 presidency, which are growth and deregulation, innovation, energy abundance and trade. The B20 recommendations on health therefore come from the business side rather than from a dedicated government track. The closest government-level link is the innovation working group, which covers standards, supply chains and skilled workforces for emerging technologies.

What business should watch

The practical questions for companies are whether governments take up harmonized approvals, so that one regulator’s review can speed another’s, and whether any G20 outcome text refers to health data standards or AI in research. Public affairs teams in the life sciences sector may want to track how health appears in the B20 plenary sessions on November 10 and 11 and in the outcome of the Leaders’ Summit in December.

Sources

Source: www.uschamber.com

Would you be against a virtual coffee & a chat? A cup of coffee framed by G7, G20, APEC and COP
Chris Atkins
Chris AtkinsPresident & Founder, Group of Nations

Would you be against a virtual coffee & a chat to see where your company fits?

Schedule your virtual coffee →

Click the image to order your virtual coffee & a chat. Pick a time that suits you; the video link comes with your calendar invitation.

More on B20

B20 page →

Read by ministers and government officials, delegations, embassies, CEOs and NGOs

We explain what was decided. Your company can show business leaders, delegations and NGOs how it gets done.

Clients that have shared their solutions

SamsungMastercardDeutsche BankPfizerBMW
Would you be against a virtual coffee & a chat to see where your company fits?
Front cover: The Advocacy Advantage by Chris Atkins

Free book · by Chris Atkins

The Advocacy Advantage

How the world’s top executives shape global stories

We’ll email you the book. Your address stays with Group of Nations.

Summit alerts

Know what is being published, before it is published.

A short note ahead of each summit — the edition in production, the deadline for inclusion, and what the presidency has put on the agenda. No more than one a month.

We publish for governments and Fortune 500 companies. Your address is used for these alerts only, and never sold.